The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Market Value Expansion Is Expected For The Implantable Pulse Generator Market Over The Forecast Period?
The implantable pulse generator market has expanded considerably in recent years. This market is set to increase from $147.01 billion in 2025 to $162.9 billion in 2026, at a compound annual growth rate (CAGR) of 10.8%. The historical growth of this market is attributable to the rising prevalence of chronic pain conditions, an increasing incidence of cardiovascular diseases, the growing adoption of implantable medical devices, the expansion of hospital-based surgical procedures, and heightened awareness of neuromodulation therapies.
The market for implantable pulse generators is projected to experience swift expansion over the coming years. By 2030, this market is anticipated to reach $245.56 billion, expanding at a compound annual growth rate (CAGR) of 10.8%. Factors driving this growth during the projection period include a heightened need for minimally invasive procedures, an expanding elderly demographic, the escalating prevalence of neurological conditions, broader availability of sophisticated implantable treatments, and a greater emphasis on sustained disease management. Key trends identified for the forecast timeframe encompass the increasing acceptance of neuromodulation therapies, the growing application of implantable pulse generators for managing chronic pain, a rising preference for rechargeable implantable pulse generators, the broadening scope of implantable pulse generator uses in movement disorders, and the escalating demand for long-term implantable stimulation devices.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18639&type=smp
What Major Growth Factors Are Impacting The Implantable Pulse Generator Market?
The increasing occurrence of neurological disorders is projected to boost the expansion of the implantable pulse generator market moving ahead. These disorders are defined as ailments impacting the brain, spinal cord, and nervous system, thereby affecting functions like movement, sensation, and cognition. The growing number of neurological disorder cases is frequently linked to elements such as an aging global population, shifts in lifestyle, environmental factors, and enhanced diagnostic methods. Implantable pulse generators assist in managing neurological disorders through the delivery of focused electrical impulses, which serve to regulate irregular neural activity and diminish symptoms. For example, data from October 2023, published by the World Federation of Neurology, a UK-based non-profit organization, indicated that more than 40% of the worldwide population presently lives with a neurological condition, and this prevalence is anticipated to nearly double in the foreseeable future. Consequently, the increased incidence of neurological disorders is fueling the expansion of the implantable pulse generator market.
What Key Segment Areas Are Included In The Implantable Pulse Generator Market Assessment?
The implantable pulse generator market covered in this report is segmented –
1) By Product Type: Functional Electrical Stimulation (FES) Devices for Motor Function Restoration, Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices
2) By Charging Type: Rechargeable, Non-Rechargeable
3) By Application: Movement Disorders, Chronic Pain Management, Neurological Disorders, Other Applications
4) By End User: Hospitals, Ambulatory Surgical Centers, Clinics, Home Care and Remote Monitoring Settings
Subsegments:
1) By Functional Electrical Stimulation (FES) Devices: For Motor Function Restoration, For Muscle Strengthening, For Rehabilitation Post-Stroke or Injury
2) By Spinal Cord Stimulation (SCS) Devices: Conventional SCS Systems, High-Frequency SCS Systems, Burst SCS Systems
3) By Deep Brain Stimulation (DBS) Devices: Parkinson’s Disease DBS Systems, Essential Tremor DBS Systems, Dystonia DBS Systems, Other Neurological Disorder DBS Systems
4) By Vagus Nerve Stimulation (VNS) Devices: Epilepsy Treatment VNS Devices, Depression Treatment VNS Devices
5) By Sacral Nerve Stimulation (SNS) Devices: Urinary Incontinence SNS Devices, Fecal Incontinence SNS Devices, Other Pelvic Floor Disorder SNS Devices
Which Trends Are Influencing The Direction Of The Implantable Pulse Generator Market?
Leading firms within the implantable pulse generator (IPG) market are focusing on MRI conditional neurostimulators, including rechargeable IPGs equipped with sensing capabilities, to enhance their market position. As an illustration, in April 2024, Medtronic, a US healthcare enterprise, secured FDA approval for its Inceptiv closed-loop spinal cord stimulator. This device continuously monitors evoked compound action potentials (ECAPs) 50 times per second to dynamically modify stimulation and supports full-body 1.5 T and 3 T MRI examinations. Likewise, in January 2024, Medtronic launched the Percept RC, a rechargeable deep brain stimulation neurostimulator that incorporates BrainSense sensing technology, offers a 15-year battery life, and is fully compatible with 1.5 T and 3 T MRI scans even while therapy is active. Such innovations improve individualized therapy and patient safety, although they might incur increased development and device expenses.
Who Are The Prominent Players Across The Implantable Pulse Generator Market?
Major companies operating in the implantable pulse generator market are Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, Nevro Corp, LivaNova PLC, NeuroPace Inc, NeuroSigma Inc, Saluda Medical Pty Ltd, Synapse Biomedical Inc, Nuvectra Medical Inc, MainStay Medical International PLC, Aleva Neurotherapeutics SA, Bioness Inc, EnteroMedics Inc, Neuronetics Inc, Axonics Inc, Sceneray Co Ltd, Cirtec Medical, BlueWind Medical, Syntach AB, Osaka Medical Devices, Gimer Medical, Saluda Medical
Access The Complete Implantable Pulse Generator Market Report:
https://www.thebusinessresearchcompany.com/report/implantable-pulse-generator-global-market-report
Which Region Stands As The Largest Contributor To The Implantable Pulse Generator Market?
North America was the largest region in the implantable pulse generator market in 2025. The regions covered in the implantable pulse generator market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Implantable Pulse Generator Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/report/implantable-pulse-generator-global-market-report
Browse Through More Reports Similar to the Global Implantable Pulse Generator Market 2026, By The Business Research Company
Implantable Heart Pacemaker Market Report 2026
https://www.thebusinessresearchcompany.com/report/implantable-heart-pacemaker-global-market-report
Implantable Cardiac Rhythm Management Device Market Report 2026
Cardiovascular Implants Market Report 2026
https://www.thebusinessresearchcompany.com/report/cardiovascular-implants-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model